Neurosteer

The Neurosteer wearable EEG system has received FDA clearance as a Class II device. It enables real-time, non-invasive monitoring of brain activity using advanced signal processing to provide both traditional frequency bands and novel "brain metrics." The system supports continuous patient monitoring in various settings—including ICU and outpatient clinics—and assists in early detection of cognitive decline and neurodegenerative diseases. Ongoing clinical trials are validating its use for additional indications such as Parkinson's disease, dementia, essential tremor, stress/anxiety management, and pain mitigation. The technology has been used in pharma drug trials to support subject screening and efficacy testing.

No published pivotal trial results yet; the product's main value proposition lies in its regulatory clearance for broad clinical utility.

Pipeline breadth cannot be quantified traditionally since this is a diagnostic/device company with one core commercialized product being validated across multiple applications.